These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma. Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755 [TBL] [Abstract][Full Text] [Related]
28. miR-125b inhibitor may enhance the invasion-prevention activity of temozolomide in glioblastoma stem cells by targeting PIAS3. Shi L; Wan Y; Sun G; Zhang S; Wang Z; Zeng Y BioDrugs; 2014 Feb; 28(1):41-54. PubMed ID: 23857508 [TBL] [Abstract][Full Text] [Related]
29. Ribosomal protein S6 promotes stem-like characters in glioma cells. Shirakawa Y; Hide T; Yamaoka M; Ito Y; Ito N; Ohta K; Shinojima N; Mukasa A; Saito H; Jono H Cancer Sci; 2020 Jun; 111(6):2041-2051. PubMed ID: 32246865 [TBL] [Abstract][Full Text] [Related]
30. BIS-mediated STAT3 stabilization regulates glioblastoma stem cell-like phenotypes. Im CN; Yun HH; Song B; Youn DY; Cui MN; Kim HS; Park GS; Lee JH Oncotarget; 2016 Jun; 7(23):35056-70. PubMed ID: 27145367 [TBL] [Abstract][Full Text] [Related]
32. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth. Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911 [TBL] [Abstract][Full Text] [Related]
33. miR-124 Acts as a Tumor Suppressor in Glioblastoma via the Inhibition of Signal Transducer and Activator of Transcription 3. Li W; Huang H; Su J; Ji X; Zhang X; Zhang Z; Wang H Mol Neurobiol; 2017 May; 54(4):2555-2561. PubMed ID: 26993295 [TBL] [Abstract][Full Text] [Related]